Background: Various strategies aimed at limiting inappropriate antimicrobial use including antibiotic time out (ATO) have been proposed to combat the development of antimicrobial resistance, yet there are limited studies that have assessed the impact of ATO on clinical outcomes. Methods: This single-center retrospective study reviewed the effect of a passive ATO strategy by comparing 100 adult patients with an ATO matched by infection type to 100 antibiotic-treated adult patients lacking an ATO note. Results: No difference in clinical outcomes was observed, however, ATO did result in improved optimization of antibiotic selection and duration, and reduction of piperacillin/tazobactam and vancomycin use. Conclusion: Further studies are warranted to evaluate the impact of ATO on clinical outcomes of a larger homogenous population with specified infectious diagnoses and clinical characteristics.
BarlamTFCosgroveSEAbboLM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51-e77.
LeeTCFrenetteCJayaramanDGreenLPiloteL.Antibiotic self-stewardship: trainee-led structured antibiotic time-outs to improve antimicrobial use. Ann Intern Med. 2014;161(10):53-58.
5.
ThomKTammaPDHarrisAD, et al. Impact of a prescriber-driven antibiotic time-out on antibiotic use. Clin Infect Dis. 2019;68(9):1581-1584.
6.
GraberCJJonesMMGlassmanPA, et al. Taking an antibiotic time-out: utilization and usability of a self-stewardship time-out program for renewal of vancomycin and piperacillin-tazobactam. Hosp Pharm. 2015;50(11):1011-1024.
7.
JonesMGraberCButlerJ, et al. Decreased vancomycin use after implementation of a decision support program for antibiotic time outs. Open Forum Infect Dis. 2014;1(1):S54.
8.
VasinaLDehnerMWongA, et al. The impact of a pharmacist driven 48-hour antibiotic time out during multi-disciplinary rounds on antibiotic utilization in a community non-teaching hospital. Open Forum Infect Dis. 2017;4(1):S272-S273.
9.
VakilNHirai-YangAGautP, et al. Antimicrobial time out: novel approach to expand antimicrobial stewardship in a large, tertiary medical center. Open Forum Infect Dis. 2015;2(1):1417.
10.
Van SchnooneveldTCRuppMELydenECavalieriJMarolfCRolekK.Randomized trial of team pharmacist-led antimicrobial time out. Open Forum Infect Dis. 2016;3(1):1942.
11.
KellumJALameireNAspelinP, et al. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1-141.
12.
JammalNMcmanusDTirmiziSTopalJ.Balancing the efficacy and safety of implementing a piperacillin/tazobactam (PTZ) antibiotic time-out. Open Forum Infect Dis. 2017;4(suppl 1):S488.
